Rezolute, Inc. — Director's Dealing 2016

Jan 11, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AntriaBio, Inc. (ANTB)
CIK: 0001509261
Period of Report: 2015-02-09

Reporting Person: Elam Nevan C (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-02-09	Common Stock	S	842949	—	Disposed	0	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-02-09	Warrant to Purchase Common Stock	$1.25	S	39117	Disposed	2019-03-31	Common Shares (39117)	Indirect
2015-12-10	Series A Convertible Preferred Stock	$1.95	P	76923	Acquired		Common Shares (76923)	Direct

Footnotes

F1: Reported securities were held by Konus Advisory Group, Inc., of which reporting person is significant holder, managing member & director. On Feb. 9, 2015, as part of extinguishment of $1,441,795 Konus debt, reported securities were transferred in entirety (giving effect to 1 for 8 reverse split). Reporting person no longer maintains voting or dispositive power of Issuer's shares & warrants previously held by Konus.

F2: The Series A Preferred Stock is convertible into common stock of Issuer at price per share of $1.95, subject to terms and conditions of Private Placement Memorandum dated November 3, 2015.

F3: The Series A Preferred Stock has no expiration date.